Assessing a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation

NCT01645371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2014-10-20

No results posted yet for this study

Summary

This qualitative research is to assess the validity of the stool symptom screener that will be used in patients with chronic opioid-induced constipation to determine the adequacy of their response to laxatives.

Conditions

  • Opioid-induced Constipation

Sponsors & Collaborators

Principal Investigators

  • Mark Sostek, MD · AstraZeneca

  • Karin S Coyne, PHD, MPH · United BioSource

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-02-28
Completion
2013-02-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645371 on ClinicalTrials.gov